Carvykti

J&J, Legend's Carvykti shows CAR-T can extend lives in multiple myeloma
Fierce Pharma
Tue, 07/2/24 - 11:22 am
JNJ
Legend Biotech
CAR-T
Carvykti
Multiple Myeloma
clinical trials
Q&A: Legend Biotech CEO on whether Carvykti can meet expectations
Medical Marketing and Media
Mon, 04/15/24 - 11:16 am
Legend Biotech
Carvykti
mutliple myeloma
JNJ
Despite early death concerns, FDA advisers back J&J and Legend's Carvykti and BMS' Abecma for earlier myeloma
Fierce Pharma
Sun, 03/17/24 - 09:30 pm
JNJ
Legend Biotech
CAR-T
FDA
Carvykti
Abecma
BMS’s Breyanzi Becomes First CAR-T Therapy for Two Types of Leukemia
BioSpace
Fri, 03/15/24 - 11:32 am
Bristol Myers Squibb
CAR-T
CLL
Breyanzi
FDA
JNJ
Carvykti
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
BioSpace
Mon, 03/11/24 - 11:53 am
CAR-T
Multiple Myeloma
FDA
Bristol Myers Squibb
2seventy bio
Abecma
JNJ
Legend Biotech
Carvykti
FDA sets date for high-profile CAR-T adcomm for Bristol's Abecma, J&J's Carvykti
Fierce Pharma
Sun, 02/4/24 - 12:39 pm
Bristol Myers Squibb
Abecma
FRDA
CAR-T
JNJ
Carvykti
J&J, Legend to Face Adcomm for Carvykti’s Push as Earlier Line MM Treatment
BioSpace
Wed, 01/24/24 - 10:40 am
JNJ
Legend Biotech
FDA
Carvykti
Multiple Myeloma
After launch limitations, Johnson & Johnson exec touts manufacturing progress on CAR-T drug Carvykti
Fierce Pharma
Wed, 10/18/23 - 07:44 pm
JNJ
Legend Biotech
Multiple Myeloma
CAR-T
Carvykti
cell therapy
J&J sees trial data supporting earlier CAR-T use in multiple myeloma
BioPharma Dive
Mon, 06/5/23 - 10:12 am
ASCO 2023
JNJ
Legend Biotech
Carvykti
CAR-T
Multiple Myeloma
J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows
Fierce Pharma
Wed, 04/19/23 - 11:24 am
CAR-T
Bristol Myers Squibb
JNJ
Legend Biotech
AACR
Multiple Myeloma
Carvykti
Abecma
Johnson & Johnson shelves Carvykti's UK launch amid manufacturing shortfalls
Fierce Pharma
Wed, 03/15/23 - 09:27 pm
JNJ
Legend Biotech
CAR-T
Carvykti
J&J, Legend’s cancer cell therapy has early success in key clinical trial
BioPharma Dive
Mon, 01/30/23 - 10:27 am
JNJ
Legend Biotech
Carvykti
Multiple Myeloma
clinical trials
cell therapy
Sales of J&J, Legend cell therapy plateau amid production challenges
BioPharma Dive
Wed, 01/25/23 - 10:57 pm
JNJ
Legend Biotech
gene therapy
Carvykti
Multiple Myeloma
A year of two halves for US approvals
EP Vantage
Thu, 01/19/23 - 09:38 am
FDA
drug approvals
Mounjaro
Eli Lilly
Vabysmo
Roche
Opdualag
Bristol Myers Squibb
Carvykti
JNJ
Vtama
Roivant
Pluvicto
Novartis
J&J’s $5bn projects have much to prove
EP Vantage
Wed, 10/19/22 - 10:37 am
JNJ
milvexian
nipocalimab
Carvykti
Rybrevant/lazertinib
J&J partner Legend Biotech looks to raise $250M amid Carvykti rollout, global expansion
Fierce Pharma
Wed, 07/27/22 - 10:28 am
JNJ
Legend Biotech
Carvykti
CAR-T
ASCO 2022 – Carvykti casts a long shadow
EP Vantage
Mon, 06/6/22 - 10:01 am
ASCO 2022
Carvykti
CAR-T
Arcellx
Gracell
Oricell
Multiple Myeloma
ASCO: J&J, Legend reveal more CAR-T data and a look at Carvykti for earlier myeloma in a difficult population
Fierce Pharma
Fri, 05/27/22 - 10:33 am
ASCO 2022
JNBJ
Legend Biotech
Carvykti
CAR-T
Multiple Myeloma
Legend Biotech Achieves Milestone Under Collaboration Agreement with Janssen Biotech, Inc. for BCMA CAR-T
BioSpace
Thu, 04/21/22 - 10:57 am
Legend Biotech
Janssen
Carvykti
cilta-cel
CAR-T
J&J, Legend cell therapy approved by FDA for multiple myeloma
BioPharma Dive
Mon, 02/28/22 - 11:44 pm
JNJ
Legend Biotech
FDA
Multiple Myeloma
Carvykti
CAR-T

Pages